This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $82,229,910.30 contract provides seasonal and pre-pandemic influenza vaccines, as well as other standard immunizations, to support disease prevention and public health preparedness for federal agencies. The IDC is a multiple award vehicle with a ceiling value of $82,229,910.30 and a period of performance extending to February 28, 2021. It does not include any set-aside designations.
Sanofi Pasteur, as the prime contractor, will fulfill task orders and provide the contracted vaccines and pharmaceuticals from its Swiftwater, Pennsylvania facility or other designated locations. The IDC leverages Sanofi Pasteur's manufacturing and distribution capabilities to efficiently meet agency requirements for vaccines and related medical countermeasures supporting public health missions across the Department of Veterans Affairs, Indian Health Service, Department of Health and Human Services, and other federal entities.
Generated 10/31/24, 9:03 AM